CLINICAL_TRIALS
trial_result
· 2025-09-03
Clinical Trial Update: The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial) [Phase 2]
Summary
The Phase 2 CLARA (ALFA 0702) trial for Acute Myeloid Leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospices Civils de Lyon | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED